Leadership Team

Biocon Biologics / About Us / Leadership Team

At Biocon Biologics, the vast experience and the strategic focus of the Leadership Team steer us towards our goals. The Leadership Team brings together seasoned professionals with various functional expertise such as Finance, Sales, Marketing, Manufacturing, R&D, Operations, Human Resources, Quality, Communications and Legal. The Leadership Team articulates BBL’s purpose, sets a clear and actionable strategy for achieving that purpose, and most importantly, motivates and empowers everyone else in the organization to succeed. It also executes its role in corporate governance through regular reviews of our financial performance and critical business issues.

EXECUTIVE COMMITTEE

SHREEHAS P TAMBE

Chief Executive Officer

and Managing Director

Kedar Upadhye

Chief Financial Officer

RHONDA DUFFY

Chief Operating Officer

MATTHEW ERICK

Chief Commercial

Officer – Advanced

Markets

SUSHEEL UMESH

Chief Commercial

Officer – Emerging

Markets

Dr. Anuj Goel

Chief Development

Officer

NAVEEN NARAYANAN

Global Head of HR

ELT

Ratish Trehan

Head of Commercial –

Emerging Markets

Joshua Salsi

Head of Commercial –

North America

Blake Leitch

Head of Commercial –

Europe

ARLENE WOLNY

Global Head of

Regulatory Affairs

GANESH REDDY

Global Head of

Manufacturing

Ankur Bhatnagar

Global Head of

R&D – CMC

DWIGHT D. HANSHEW, Jr.

Chief Quality Officer

Kathleen Blanchard

Global General Counsel

UWE GUDAT

Chief Medical Officer

SEEMA AHUJA

Global Head of

Corporate Brand & Head

of Communications – EMs

STEPHANIE WASCO

Head of Communications

– Advanced Markets

STEPHEN J. FECHO, Jr.

Global Head –

Supply Chain Management

AKHILESH NAND

Global Head – GRC

(Governance, Risk,

Compliance) &

Company Secretary

MANDAR S GHATNEKAR

Global Head of IT &

Digital Transformation

We are Transforming Healthcare. Transforming Lives!

Biocon Biologics is a unique, fully integrated leading global biosimilars player with established capabilities in the development, manufacturing and commercialization of high-quality biosimilars. Our 40-year legacy of being on the cutting edge of science has enabled us to simultaneously build global scale with a competitive cost structure. With a comprehensive portfolio of biosimilars, Biocon Biologics is transforming healthcare, transforming lives.